German Cancer Research Center, Heidelberg, Germany.
Institut für Pathologie, Universitätsmedizin Greifswald, Greifswald, Germany.
Hepatobiliary Pancreat Dis Int. 2017 Dec 15;16(6):570-594. doi: 10.1016/S1499-3872(17)60071-7.
Clear cell hepatocellular carcinoma (CCHCC) has hitherto been considered an uncommon, highly differentiated variant of hepatocellular carcinoma (HCC) with a relatively favorable prognosis. CCHCC is composed of mixtures of clear and/or acidophilic ground glass hepatocytes with excessive glycogen and/or fat and shares histology, clinical features and etiology with common HCCs. Studies in animal models of chemical, hormonal and viral hepatocarcinogenesis and observations in patients with chronic liver diseases prone to develop HCC have shown that the majority of HCCs are preceded by, or associated with, focal or diffuse excessive storage of glycogen (glycogenosis) which later may be replaced by fat (lipidosis/steatosis). In ground glass cells, the glycogenosis is accompanied by proliferation of the smooth endoplasmic reticulum, which is closely related to glycogen particles and frequently harbors the hepatitis B surface antigen (HBsAg). From the findings in animal models a sequence of changes has been established, commencing with preneoplastic glycogenotic liver lesions, often containing ground glass cells, and progressing to glycogen-poor neoplasms via various intermediate stages, including glycogenotic/lipidotic clear cell foci, clear cell hepatocellular adenomas (CCHCA) rich in glycogen and/or fat, and CCHCC. A similar process seems to take place in humans, with clear cells frequently persisting in CCHCC and steatohepatitic HCC, which presumably represent intermediate stages in the development rather than particular variants of HCC. During the progression of the preneoplastic lesions, the clear and ground glass cells transform into cells characteristic of common HCC. The sequential cellular changes are associated with metabolic aberrations, which start with an activation of the insulin signaling cascade resulting in pre-neoplastic hepatic glycogenosis. The molecular and metabolic changes underlying the glycogenosis/lipidosis are apparently responsible for the dramatic metabolic shift from gluconeogenesis to the pentose phosphate pathway and Warburg-type glycolysis, which provide precursors and energy for an ever increasing cell proliferation during progression.
透明细胞型肝细胞癌(CCHCC)以往被认为是一种罕见的、高度分化的肝细胞癌(HCC)变体,预后相对较好。CCHCC 由透明和/或嗜酸性磨砂玻璃样肝细胞的混合物组成,具有过多的糖原和/或脂肪,并具有与常见 HCC 相同的组织学、临床特征和病因。化学、激素和病毒性肝癌发生的动物模型研究以及易发生 HCC 的慢性肝病患者的观察结果表明,大多数 HCC 之前或与之相关的是局灶性或弥漫性糖原过度储存(糖原沉积症),随后可能被脂肪(脂肪变性/脂肪变性)取代。在磨砂玻璃细胞中,糖原沉积症伴随着光滑内质网的增殖,它与糖原颗粒密切相关,并且经常含有乙型肝炎表面抗原(HBsAg)。从动物模型的研究结果中建立了一个变化序列,从具有磨砂玻璃细胞的癌前糖原沉积性肝病变开始,然后通过各种中间阶段进展为糖原贫乏的肿瘤,包括糖原/脂肪性透明细胞灶、富含糖原和/或脂肪的透明细胞肝细胞腺瘤(CCHCA)以及 CCHCC。在人类中似乎也发生了类似的过程,透明细胞经常存在于 CCHCC 和脂肪性肝炎性 HCC 中,这两种肿瘤可能代表 HCC 发展的中间阶段,而不是 HCC 的特定变体。在癌前病变的进展过程中,透明细胞和磨砂玻璃细胞转化为具有普通 HCC 特征的细胞。连续的细胞变化与代谢异常有关,这些异常始于胰岛素信号级联的激活,导致前癌性肝糖原沉积症。糖原沉积症/脂肪变性的分子和代谢变化显然是导致从糖异生到戊糖磷酸途径和瓦博格型糖酵解的剧烈代谢转变的原因,这种转变为不断增加的细胞增殖提供了前体和能量。